Published in J Allergy Clin Immunol on November 28, 2013
Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat Biotechnol (2014) 2.99
Crystal structure of the V(D)J recombinase RAG1-RAG2. Nature (2015) 1.24
Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development. J Allergy Clin Immunol (2014) 1.07
Molecular Mechanism of V(D)J Recombination from Synaptic RAG1-RAG2 Complex Structures. Cell (2015) 1.04
A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency. J Allergy Clin Immunol (2014) 0.99
Next generation sequencing reveals skewing of the T and B cell receptor repertoires in patients with wiskott-Aldrich syndrome. Front Immunol (2014) 0.92
Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. J Clin Invest (2015) 0.90
History and current status of newborn screening for severe combined immunodeficiency. Semin Perinatol (2015) 0.89
Identification of patients with RAG mutations previously diagnosed with common variable immunodeficiency disorders. J Clin Immunol (2014) 0.89
RAG1 deficiency may present clinically as selective IgA deficiency. J Clin Immunol (2015) 0.83
Rag defects and thymic stroma: lessons from animal models. Front Immunol (2014) 0.81
Exome and genome sequencing for inborn errors of immunity. J Allergy Clin Immunol (2016) 0.80
Atypical severe combined immunodeficiency caused by a novel homozygous mutation in Rag1 gene in a girl who presented with pyoderma gangrenosum: a case report and literature review. J Clin Immunol (2014) 0.79
Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency. J Allergy Clin Immunol (2015) 0.79
Clinical Spectrum of SCID: The Key is in the Thymus? Front Immunol (2014) 0.78
PON-P and PON-P2 predictor performance in CAGI challenges: Lessons learned. Hum Mutat (2017) 0.78
A Toddler With Rash, Encephalopathy, and Hemolytic Anemia. J Pediatric Infect Dis Soc (2015) 0.77
Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies. Blood (2016) 0.77
Rapid generation of novel models of RAG1 deficiency by CRISPR/Cas9-induced mutagenesis in murine zygotes. Oncotarget (2016) 0.77
Lessons in gene hunting: a RAG1 mutation presenting with agammaglobulinemia and absence of B cells. J Allergy Clin Immunol (2014) 0.77
Characterization of T and B cell repertoire diversity in patients with RAG deficiency. Sci Immunol (2016) 0.76
Programmed DNA breaks in lymphoid cells: repair mechanisms and consequences in human disease. Immunology (2015) 0.76
RAG1 reversion mosaicism in a patient with Omenn syndrome. J Clin Immunol (2014) 0.76
Mutation c.256_257delAA in RAG1 Gene in Polish Children with Severe Combined Immunodeficiency: Diversity of Clinical Manifestations. Arch Immunol Ther Exp (Warsz) (2017) 0.75
Estimated disease incidence of RAG1/2 mutations: A case report and querying the Exome Aggregation Consortium. J Allergy Clin Immunol (2016) 0.75
Recombinase Activating Gene 1 Deficiencies Without Omenn Syndrome May Also Present With Eosinophilia and Bone Marrow Fibrosis. J Clin Med Res (2016) 0.75
Late Onset Hypomorphic RAG2 Deficiency Presentation with Fatal Vaccine-Strain VZV Infection. J Clin Immunol (2015) 0.75
Compound heterozygous mutation of Rag1 leading to Omenn syndrome. PLoS One (2015) 0.75
Genetic Counseling in Primary Immunodeficiency Disorders: An Emerging Experience in Egypt. Mol Diagn Ther (2017) 0.75
Predominant autoantibody production by early human B cell precursors. Science (2003) 13.14
The defect in murine severe combined immune deficiency: joining of signal sequences but not coding segments in V(D)J recombination. Cell (1988) 4.34
ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature (2006) 3.35
Partial V(D)J recombination activity leads to Omenn syndrome. Cell (1998) 3.18
RAG mutations in human B cell-negative SCID. Science (1996) 3.03
High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets. Proc Natl Acad Sci U S A (2010) 2.74
V(D)J recombination: mechanisms of initiation. Annu Rev Genet (2011) 2.70
CTCF-binding elements mediate control of V(D)J recombination. Nature (2011) 2.62
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood (2001) 2.50
Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol (1994) 2.45
Mechanisms of programmed DNA lesions and genomic instability in the immune system. Cell (2013) 2.32
A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines. Nat Immunol (2002) 2.07
RAG-dependent primary immunodeficiencies. Hum Mutat (2006) 1.91
A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest (2005) 1.77
An immunodeficiency disease with RAG mutations and granulomas. N Engl J Med (2008) 1.71
A variant of SCID with specific immune responses and predominance of gamma delta T cells. J Clin Invest (2005) 1.54
Idiopathic CD4+ T lymphopenia without autoimmunity or granulomatous disease in the slipstream of RAG mutations. Blood (2011) 1.53
PON-P: integrated predictor for pathogenicity of missense variants. Hum Mutat (2012) 1.48
Hypomorphic Rag mutations can cause destructive midline granulomatous disease. Blood (2010) 1.47
Structure of the RAG1 nonamer binding domain with DNA reveals a dimer that mediates DNA synapsis. Nat Struct Mol Biol (2009) 1.40
Development of the expressed Ig CDR-H3 repertoire is marked by focusing of constraints in length, amino acid use, and charge that are first established in early B cell progenitors. J Immunol (2005) 1.40
Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency. Clin Immunol (2011) 1.38
Highly variable clinical phenotypes of hypomorphic RAG1 mutations. Pediatrics (2010) 1.30
Immunoglobulin analysis tool: a novel tool for the analysis of human and mouse heavy and light chain transcripts. Front Immunol (2012) 1.25
Defect of regulatory T cells in patients with Omenn syndrome. J Allergy Clin Immunol (2010) 1.21
Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation. Blood (2009) 1.19
Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development. J Allergy Clin Immunol (2014) 1.07
Analysis of mutations from SCID and Omenn syndrome patients reveals the central role of the Rag2 PHD domain in regulating V(D)J recombination. J Clin Invest (2010) 1.02
Expanding the spectrum of recombination-activating gene 1 deficiency: a family with early-onset autoimmunity. J Allergy Clin Immunol (2013) 0.97
Estimation of D segment usage in initial D to JH joinings in a murine immature B cell line. Preferential usage of DFL16.1, the most 5' D segment and DQ52, the most JH-proximal D segment. J Immunol (1990) 0.94
Novel mutations in RAG1/2 and ADA genes in Israeli patients presenting with T-B-SCID or Omenn syndrome. Clin Immunol (2011) 0.93
Recombinase-activating gene 1 immunodeficiency: different immunological phenotypes in three siblings. Acta Paediatr (2009) 0.91
Analysis of mutations and recombination activity in RAG-deficient patients. Clin Immunol (2010) 0.88
Adult lupus-prone MRL/MpJ2+ mice express a primary antibody repertoire that differs in CDR-H3 length distribution and hydrophobicity from that expressed in the C3H parental strain. Mol Immunol (2004) 0.86
Novel RAG1 mutation in a case of severe combined immunodeficiency. Pediatrics (2005) 0.84
A RAG1 mutation found in Omenn syndrome causes coding flank hypersensitivity: a novel mechanism for antigen receptor repertoire restriction. J Immunol (2008) 0.79
IL7R and RAG1/2 genes mutations/polymorphisms in patients with SCID. Iran J Allergy Asthma Immunol (2011) 0.78
Finding our way through phenotypes. PLoS Biol (2015) 1.53
Proper reporting of predictor performance. Nat Methods (2014) 1.45
PON-P2: prediction method for fast and reliable identification of harmful variants. PLoS One (2015) 1.05
Plasmacytoid dendritic cell depletion in DOCK8 deficiency: rescue of severe herpetic infections with IFN-α 2b therapy. J Allergy Clin Immunol (2014) 0.94
Dedicator of cytokinesis 8-deficient patients have a breakdown in peripheral B-cell tolerance and defective regulatory T cells. J Allergy Clin Immunol (2014) 0.93
A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet (2015) 0.84
Broad spectrum of autoantibodies in patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia. J Allergy Clin Immunol (2015) 0.84
Clinical predictors of primary immunodeficiency diseases in children. Allergy Asthma Immunol Res (2012) 0.80
Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes TH17 cell differentiation. J Allergy Clin Immunol (2016) 0.79
Consanguinity and primary immunodeficiencies. Hum Hered (2014) 0.77
Characterization of T and B cell repertoire diversity in patients with RAG deficiency. Sci Immunol (2016) 0.76
A prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis. J Allergy Clin Immunol (2016) 0.76
Differences in Granule Morphology yet Equally Impaired Exocytosis among Cytotoxic T Cells and NK Cells from Chediak-Higashi Syndrome Patients. Front Immunol (2017) 0.75
Detection of Sp110 by Flow Cytometry and Application to Screening Patients for Veno-occlusive Disease with Immunodeficiency. J Clin Immunol (2017) 0.75
International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity. J Clin Immunol (2017) 0.75
Simulation of the dynamics of primary immunodeficiencies in CD4+ T-cells. PLoS One (2017) 0.75
The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies. J Clin Immunol (2017) 0.75